4D PHARMA PLC (LBPS)
Institutional ownership reported to the SEC as of Q2 2022, across 6 quarters.
8
Reporting holders
$430.0K
Reported value
0.0%
Held as options
-2
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Ruffer LLP | $320.0K | 195,954 | 0.01% | 5q | HELD |
| CITADEL ADVISORS LLC | $46.0K | 28,166 | 0.00% | 2q | -10.7%-$5.5K |
| CAPSTONE INVESTMENT ADVISORS, LLC | $25.0K | 15,200 | 0.00% | 2q | HELD |
| WOLVERINE ASSET MANAGEMENT LLC | $13.0K | 8,055 | 0.00% | 4q | HELD |
| Tower Research Capital LLC (TRC) | $8.0K | 4,643 | 0.00% | 2q | -45.4%-$6.7K |
| ADVISOR GROUP HOLDINGS, INC. | $8.0K | 4,799 | 0.00% | 6q | +12.3% |
| MORGAN STANLEY | $7.0K | 4,360 | 0.00% | 6q | -89.9%-$62.6K |
| CREDIT SUISSE AG/ | $3.0K | 1,638 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2022 | 8 | $430.0K | 262,815 | 1 | 1 | 3 | 0.0% |
| Q1 2022 | 10 | $2.0M | 420,890 | 4 | 3 | 0 | 0.0% |
| Q4 2021 | 7 | $1.9M | 343,090 | 1 | 2 | 2 | 0.0% |
| Q3 2021 | 6 | $2.1M | 344,385 | 2 | 0 | 2 | 0.0% |
| Q2 2021 | 4 | $2.4M | 222,397 | 1 | 2 | 0 | 0.0% |
| Q1 2021 | 7 | $2.7M | 226,065 | 7 | 0 | 0 | 0.0% |